Email ID
Password
Sign me in automatically next time
clinica
RECENT TWEETS    
22 October 2014

 
22 October 2014
Oversight of medical device and drug policy in the EU is to remain with the European Commission’s health directorate (DG Sanco), and not with the industry directorate (DG ENTR). The news was announced just before the European Parliament today voted ...
21 October 2014
Germany has traditionally been Europe’s largest medtech market. But with governments having to tighten their budgets as a fallout of the recession over the last five years, how has German medtech manufacturers adapted to this changing environment? ...
21 October 2014
The resignation of the head of the European Commission's health directorate (DG Sanco), director general Paola Testori Coggi, will cause a headache for the commission in terms of finding a suitable replacement, but is unlikely to have any impact on ...
20 October 2014
The US has already moved ahead in implementing unique device identification requirements which help to identify medical devices through their distribution and use. In the EU, there is also growing demand for such a system but what is holding the ...
 
22 October 2014
bioMérieux’s third quarter was “broadly in line” with expectations, according to Jefferies analyst Peter Welford. Q3 sales of €412m ($523m) grew 6% year-on-year, with 2.3% organic growth similar to his prediction of 2.6%, but “shy of +3.1% ...
22 October 2014
A Swedish start-up with a ceramic bone implant is one step closer to carving itself a space in the €1.5m ($1.9m) bone repair market. OssDsign has received 510(k) clearance from the US FDA to commercialize its bioceramic burr hole plug, Cranioplug. ...
21 October 2014
Genome sequencing firm Illumina beat analysts’ expectations in its third quarter, with sales of $481m, up 35% year-on-year and 7% above the consensus estimate of $451m. This was the highest year-on-year growth since Q2 2011 and marked the twelfth ...
21 October 2014
The resignation of the head of the European Commission's health directorate (DG Sanco), director general Paola Testori Coggi, will cause a headache for the commission in terms of finding a suitable replacement, but is unlikely to have any impact on ...
 
22 October 2014
bioMérieux’s third quarter was “broadly in line” with expectations, according to Jefferies analyst Peter Welford. Q3 sales of €412m ($523m) grew 6% year-on-year, with 2.3% organic growth similar to his prediction of 2.6%, but “shy of +3.1% ...
21 October 2014
Germany has traditionally been Europe’s largest medtech market. But with governments having to tighten their budgets as a fallout of the recession over the last five years, how has German medtech manufacturers adapted to this changing environment? ...
21 October 2014
Genome sequencing firm Illumina beat analysts’ expectations in its third quarter, with sales of $481m, up 35% year-on-year and 7% above the consensus estimate of $451m. This was the highest year-on-year growth since Q2 2011 and marked the twelfth ...
20 October 2014
Boston Scientific is set for more improvement in Q3, analysts believe. The company, which is due to report results on 22 October, will see revenues grow 5% year-on-year to $1.82bn, within previous guidance of $1.79-1.84bn, according to analyst ...
 
22 October 2014
Oversight of medical device and drug policy in the EU is to remain with the European Commission’s health directorate (DG Sanco), and not with the industry directorate (DG ENTR). The news was announced just before the European Parliament today voted ...
21 October 2014
The resignation of the head of the European Commission's health directorate (DG Sanco), director general Paola Testori Coggi, will cause a headache for the commission in terms of finding a suitable replacement, but is unlikely to have any impact on ...
20 October 2014
The US has already moved ahead in implementing unique device identification requirements which help to identify medical devices through their distribution and use. In the EU, there is also growing demand for such a system but what is holding the ...
20 October 2014
The Dutch government has made remote patient management - and the regulatory oversight of the products needed to achieve this objective – a priority. Amanda Maxwell spoke with Dr Stefan Visscher at the Dutch Health Care Inspectorate (IGZ) to find ...
 
Amedica gets surgical expertise with new CEO Orthopedic firm Amedica has appointed existing chair and board member Sonny Bal president and CEO. He replaces Eric Olson, who has been heading up ...
Thoratec goes back to the future with CEO appointment Keith Grossman has retaken the helm of left-ventricular-assist-device manufacturer Thoratec after an eight-and-a-half year hiatus. Mr Grossman has ...
Insulet bags veteran Patrick Sullivan as new CEO Insulin pump specialist Insulet has appointed Patrick Sullivan CEO, with long-time leader Duane DeSisto retiring after 13 years with the firm. ...
09 October 2014
Peter Charlish

Personalized medicine may not yet be a reality but, as a meeting of the Society for Medicines Research heard in London last week, considerable progress has nonetheless already been made towards that goal. In the UK, for example, a number of ...

08 October 2014
Ashley Yeo

Whether by design, chance or attrition, the messages being delivered about the value that IVDs provide in ensuring efficient care and cost-effective patient pathways are hitting home better than usual. At a time when NHS Confederation chief ...

 
22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

09 October 2014
Peter Charlish

Personalized medicine may not yet be a reality but, as a meeting of the Society for Medicines Research heard in London last week, considerable progress has nonetheless already been made towards that goal. In the UK, for example, a number of ...

08 October 2014
Ashley Yeo

Whether by design, chance or attrition, the messages being delivered about the value that IVDs provide in ensuring efficient care and cost-effective patient pathways are hitting home better than usual. At a time when NHS Confederation chief ...

 
22 September 2014
Madeleine Armstrong

Many companies and researchers are trying to develop a blood test for Alzheimer’s disease – but Norway’s Pre Diagnostics is taking a different approach that it believes will give it the edge over its rivals. Clinica spoke to chief scientific officer ...

 
“Beyond Compliance”: a self regulation tool to add strength to the CE marking – podcast
16 December 2013
Get the Flash Player to see this player.
 

22 October 2014
Amanda Maxwell

The future regulation of high-risk devices is one of the trickiest subjects in the proposed EU Medical Device Regulation (MDR) on which to reach final agreement, with the different parties involved seemingly at loggerheads. Delegates at the European ...

 
31 May 2012
Hua Gong

Cancer diagnostics provide a promising future for unraveling the mystery of one of the leading killer diseases and helping to better detect and treat it. However, companies are currently facing a number of potential challenges when developing cancer ...

 
21 October 2014

Clinica’s Medtech Ventures: Origin Sciences Specialty area(s): Gastrointestinal disease detection and monitoring Based in: Cambridge, UK Founded in: 2004 No. of employees: 7 Total investment received to date:  £7.5m ($12.0m) Investors:  Animatrix ...

 
24 November 2011
Phil Greenfield

Clinica’s Patent Watch focuses on key growth areas of regenerative medicine, or where there is potential to selectively treat disease with drugs in personalised treatments, as is the case with emerging areas of drug delivery and molecular ...

 
 
 
© 2014 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36